Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

104 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.
Harnden P, Mahmood N, Southgate J. Harnden P, et al. Lancet. 1999 Mar 20;353(9157):974-7. doi: 10.1016/S0140-6736(98)05383-5. Lancet. 1999. PMID: 10459907
FGFR3 expression in primary invasive bladder cancers and matched lymph node metastases.
Turo R, Harnden P, Thygesen H, Fleischmann A, Thalmann GN, Seiler R, Cross WR, Knowles MA. Turo R, et al. Among authors: harnden p. J Urol. 2015 Jan;193(1):325-30. doi: 10.1016/j.juro.2014.06.026. Epub 2014 Jun 13. J Urol. 2015. PMID: 24933362 Free article.
Does the extent of carcinoma in prostatic biopsies predict prostate-specific antigen recurrence? A systematic review.
Harnden P, Shelley MD, Naylor B, Coles B, Mason MD. Harnden P, et al. Eur Urol. 2008 Oct;54(4):728-39. doi: 10.1016/j.eururo.2008.06.068. Epub 2008 Jun 26. Eur Urol. 2008. PMID: 18603352 Review.
The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? A systematic review and meta-analysis.
Harnden P, Naylor B, Shelley MD, Clements H, Coles B, Mason MD. Harnden P, et al. Cancer. 2008 Mar 1;112(5):971-81. doi: 10.1002/cncr.23277. Cancer. 2008. PMID: 18186496 Review.
The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review.
Harnden P, Shelley MD, Clements H, Coles B, Tyndale-Biscoe RS, Naylor B, Mason MD. Harnden P, et al. Cancer. 2007 Jan 1;109(1):13-24. doi: 10.1002/cncr.22388. Cancer. 2007. PMID: 17123267 Review.
A critical appraisal of the classification of urothelial tumours: time for a review of the evidence and a radical change?
Harnden P. Harnden P. BJU Int. 2007 Apr;99(4):723-5. doi: 10.1111/j.1464-410X.2006.06672.x. Epub 2006 Nov 28. BJU Int. 2007. PMID: 17155966 No abstract available.
Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder.
Booth C, Harnden P, Selby PJ, Southgate J. Booth C, et al. Among authors: harnden p. J Pathol. 2002 Nov;198(3):359-68. doi: 10.1002/path.1214. J Pathol. 2002. PMID: 12375269
Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitor.
Diggle CP, Cruickshank S, Olsburgh JD, Pellegrin S, Smith B, Banks RE, Selby PJ, Knowles MA, Southgate J, Harnden P. Diggle CP, et al. Among authors: harnden p. Am J Pathol. 2003 Aug;163(2):493-504. doi: 10.1016/S0002-9440(10)63678-4. Am J Pathol. 2003. PMID: 12875970 Free PMC article.
Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting.
Nirmalan NJ, Harnden P, Selby PJ, Banks RE. Nirmalan NJ, et al. Among authors: harnden p. J Pathol. 2009 Mar;217(4):497-506. doi: 10.1002/path.2504. J Pathol. 2009. PMID: 19156775
MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.
Choudhury A, Nelson LD, Teo MT, Chilka S, Bhattarai S, Johnston CF, Elliott F, Lowery J, Taylor CF, Churchman M, Bentley J, Knowles MA, Harnden P, Bristow RG, Bishop DT, Kiltie AE. Choudhury A, et al. Among authors: harnden p. Cancer Res. 2010 Sep 15;70(18):7017-26. doi: 10.1158/0008-5472.CAN-10-1202. Cancer Res. 2010. PMID: 20843819 Free PMC article.
104 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page